[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SE509130C2 - Stereospecifikt förfarande för framställning av furo/3,4-c/ pyridinenantiomerer - Google Patents

Stereospecifikt förfarande för framställning av furo/3,4-c/ pyridinenantiomerer

Info

Publication number
SE509130C2
SE509130C2 SE8904104A SE8904104A SE509130C2 SE 509130 C2 SE509130 C2 SE 509130C2 SE 8904104 A SE8904104 A SE 8904104A SE 8904104 A SE8904104 A SE 8904104A SE 509130 C2 SE509130 C2 SE 509130C2
Authority
SE
Sweden
Prior art keywords
group
carbon atoms
groups
agent
pyridine
Prior art date
Application number
SE8904104A
Other languages
English (en)
Swedish (sv)
Other versions
SE8904104D0 (sv
SE8904104L (sv
Inventor
Marc Bonato
Charles Eck
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of SE8904104D0 publication Critical patent/SE8904104D0/xx
Publication of SE8904104L publication Critical patent/SE8904104L/xx
Publication of SE509130C2 publication Critical patent/SE509130C2/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
SE8904104A 1988-04-06 1989-12-05 Stereospecifikt förfarande för framställning av furo/3,4-c/ pyridinenantiomerer SE509130C2 (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888808001A GB8808001D0 (en) 1988-04-06 1988-04-06 Stereospecific preparative process for furol(3,4-c)pyridine derivatives
PCT/FR1989/000157 WO1989009772A1 (fr) 1988-04-06 1989-04-06 PROCEDE STEREOSPECIFIQUE POUR LA PREPARATION DES ENANTIOMERES DE LA FURO[3,4-c]PYRIDINE, COMPOSES AINSI OBTENUS ET COMPOSITIONS THERAPEUTIQUES A BASE DE CES COMPOSES

Publications (3)

Publication Number Publication Date
SE8904104D0 SE8904104D0 (sv) 1989-12-05
SE8904104L SE8904104L (sv) 1989-12-05
SE509130C2 true SE509130C2 (sv) 1998-12-07

Family

ID=10634633

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8904104A SE509130C2 (sv) 1988-04-06 1989-12-05 Stereospecifikt förfarande för framställning av furo/3,4-c/ pyridinenantiomerer

Country Status (28)

Country Link
US (1) US5026855A (xx)
EP (1) EP0337858B1 (xx)
JP (1) JP2680456B2 (xx)
KR (1) KR970005308B1 (xx)
AT (1) AT397093B (xx)
AU (1) AU616753B2 (xx)
BE (1) BE1003843A4 (xx)
CA (1) CA1338475C (xx)
CH (1) CH680000A5 (xx)
DK (1) DK167020B1 (xx)
DZ (1) DZ1335A1 (xx)
ES (1) ES2057159T3 (xx)
FI (1) FI93116C (xx)
FR (2) FR2629821B1 (xx)
GB (2) GB8808001D0 (xx)
IE (1) IE61915B1 (xx)
IN (1) IN172987B (xx)
MA (1) MA21529A1 (xx)
MY (1) MY104424A (xx)
NL (1) NL8920307A (xx)
NZ (1) NZ228614A (xx)
OA (1) OA09247A (xx)
PT (1) PT90210B (xx)
SE (1) SE509130C2 (xx)
SG (1) SG40492G (xx)
TN (1) TNSN89043A1 (xx)
WO (1) WO1989009772A1 (xx)
ZA (1) ZA892477B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8808001D0 (en) * 1988-04-06 1988-05-05 Scras Stereospecific preparative process for furol(3,4-c)pyridine derivatives
GB8907480D0 (en) * 1989-04-03 1989-05-17 Scaras Societe De Conseils De Separation of insomers of furo(3,4-c)pyridine derivatives
GB8917168D0 (en) * 1989-07-27 1989-09-13 Scras Asymmetric synthesis of furo(3,4-c)pyridine derivatives
US5130252A (en) * 1990-05-14 1992-07-14 Synthetech, Inc. Resolution of furopyridine enantiomers and synthetic precursors thereof
US20060089374A1 (en) * 2003-07-17 2006-04-27 Glenn Cornett Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease
GB2423927A (en) * 2003-08-29 2006-09-13 Cotherix Inc Combination Of Cicletanine And An Oral Antidiabetic And/Or Blood Lipid-Lowering Agent For Treating Diabetes And Metabolic Syndrome
US20060154959A1 (en) * 2005-01-13 2006-07-13 Navitas Pharma Combination therapies of cicletanine and carvedilol
US20080096915A1 (en) * 2005-01-13 2008-04-24 Greenberg Traurig LLP Compositions for the treatment of metabolic disorders
US20070141174A1 (en) * 2005-01-13 2007-06-21 Navitas Pharma, Inc. Enantiomeric compositions of cicletanine, in combination with other agents, for the treatment of hypertension
US20070105817A1 (en) * 2005-11-09 2007-05-10 Jim Page Use of cicletanine and other furopyridines for treatment of systolic-predominant hypertension, isolated systolic hypertension, elevated pulse pressure, and general hypertension
JP2010514841A (ja) * 2007-01-03 2010-05-06 グレン ブイ． コルネット， 肺疾患および心疾患の処置におけるシクレタニンおよびｐｋｃ阻害剤
AR073259A1 (es) * 2008-07-29 2010-10-28 Merck & Co Inc Derivados de furosemida utiles como diureticos
WO2011043914A1 (en) * 2009-10-09 2011-04-14 Merck Sharp & Dohme Corp. Diuretics
US9522138B2 (en) * 2013-12-31 2016-12-20 Don C. Rockey Systems, methods, techniques, and compounds in research and treatment of portal hypertension and other conditions

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4244951A (en) * 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
IN156817B (xx) * 1981-02-10 1985-11-09 Scras
ZA842029B (en) * 1983-04-05 1984-10-31 Scras Furo-(3,4-c)-pyridine derivatives preparation thereof and therapeutic compositions containing the same
GB2137618B (en) * 1983-04-05 1986-05-08 Scras Furo-(3,4-c)-pyridine derivatives
IN160104B (xx) * 1983-04-05 1987-06-27 Scras
US4735950A (en) * 1983-04-05 1988-04-05 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S) Furo-(3,4-C)-pyridine derivatives and therapeutic composition containing the same
GB8327817D0 (en) * 1983-10-18 1983-11-16 Scras 4-halo-furo-(3 4-c)-pyridine derivatives
GB8330517D0 (en) * 1983-11-16 1983-12-21 Scras 6-vinyl-furo-(3,4-c)pyridine derivatives
GB8330658D0 (en) * 1983-11-17 1983-12-29 Scras 7-carboxymethoxy-furo-(3,4-c)-pyridine derivatives
GB8402740D0 (en) * 1984-02-02 1984-03-07 Scras Furo-(3 4-c)-pyridine derivatives
GB8414559D0 (en) * 1984-06-07 1984-07-11 Scras Pyridine derivatives
GB8422029D0 (en) * 1984-08-31 1984-10-03 Scras 6-substituted-furo-(3 4-c)-pyridine derivatives
GB8422379D0 (en) * 1984-09-05 1984-10-10 Scras Derivatives
GB8427218D0 (en) * 1984-10-27 1984-12-05 Scras Pyridine derivatives
DE3519693A1 (de) * 1985-06-01 1987-01-02 Basf Ag Pyridin-derivate, ihre herstellung und verwendung
GB8808001D0 (en) * 1988-04-06 1988-05-05 Scras Stereospecific preparative process for furol(3,4-c)pyridine derivatives
GB8907480D0 (en) * 1989-04-03 1989-05-17 Scaras Societe De Conseils De Separation of insomers of furo(3,4-c)pyridine derivatives

Also Published As

Publication number Publication date
NZ228614A (en) 1990-11-27
KR900700483A (ko) 1990-08-13
GB8927509D0 (en) 1990-06-13
IE61915B1 (en) 1994-11-30
MY104424A (en) 1994-03-31
GB8808001D0 (en) 1988-05-05
NL8920307A (nl) 1990-03-01
DK167020B1 (da) 1993-08-16
ES2057159T3 (es) 1994-10-16
FR2629820B1 (fr) 1993-12-03
PT90210B (pt) 1994-06-30
CA1338475C (en) 1996-07-23
EP0337858A1 (fr) 1989-10-18
EP0337858B1 (fr) 1994-06-08
AT397093B (de) 1994-01-25
AU3419089A (en) 1989-11-03
SG40492G (en) 1992-06-12
SE8904104D0 (sv) 1989-12-05
GB2235194B (en) 1992-01-29
AU616753B2 (en) 1991-11-07
KR970005308B1 (ko) 1997-04-15
GB2235194A (en) 1991-02-27
FI93116B (fi) 1994-11-15
ATA900589A (de) 1993-06-15
FI93116C (fi) 1995-02-27
DZ1335A1 (fr) 2004-09-13
MA21529A1 (fr) 1989-12-31
DK611689A (da) 1989-12-05
IN172987B (xx) 1994-01-15
TNSN89043A1 (fr) 1991-02-04
PT90210A (pt) 1989-11-10
FI895826A0 (fi) 1989-12-05
WO1989009772A1 (fr) 1989-10-19
SE8904104L (sv) 1989-12-05
ZA892477B (en) 1989-12-27
JP2680456B2 (ja) 1997-11-19
BE1003843A4 (fr) 1992-06-30
DK611689D0 (da) 1989-12-05
IE891076L (en) 1989-10-06
JPH02504394A (ja) 1990-12-13
FR2629820A1 (fr) 1989-10-13
US5026855A (en) 1991-06-25
FR2629821A1 (fr) 1989-10-13
OA09247A (fr) 1992-06-30
FR2629821B1 (fr) 1993-12-03
CH680000A5 (xx) 1992-05-29

Similar Documents

Publication Publication Date Title
Overman et al. Synthetic applications of N-acylamino-1, 3-dienes. 10. Importance of allylic interactions and stereoelectronic effects in dictating the steric course of the reaction of iminium ions with nucleophiles. An efficient total synthesis of (.+-.)-gephyrotoxin
Nicolaou et al. Synthesis of zaragozic acid A/squalestatin S1
US4584294A (en) Fused tricyclic lactams as angiotensin converting enzyme inhibitors and as antihypertensive agents
SE509130C2 (sv) Stereospecifikt förfarande för framställning av furo/3,4-c/ pyridinenantiomerer
CH644116A5 (de) Imidazolderivate.
EP0036663B1 (de) Oxiranbuttersäure-Derivate, ihre Herstellung und Verwendung, sowie diese enthaltende Arzneimittel
Hendrickson et al. Stereospecific total synthesis of hemanthidine and tazettine
Freeman et al. Electrophile-mediated cyclizations of 6-O-benzyl-1, 2-di-deoxy-3, 4-O-isopropylidene-d-ribo-hex-1-enitol to derivatives of 2, 5-anhydro-6-O-benzyl-3, 4-O-isopropylidene-d-altro-hexitol
Winstead Ferrocenophanes. Improved synthesis of 3-phenyl [5] ferrocenophane-1, 5-dione involving a reverse aldol condensation
DD275689A5 (de) Verfahren zur herstellung von enolethern von 6-chlor-4-hydroxy-2-methyl-n-(2-pyridyl)-2h-thieno(2,3-e)-1,2-thiazin-3-carbonsaeureamid-1,1-dioxid
BE867095A (fr) Nouveaux derives sesquiterpeniques utiles notamment comme inhibiteurs du systeme complementaire et leurs procedes de preparation
US4895852A (en) Antitumor alkaloids
KR820001262B1 (ko) 세스키테르펜 유도체의 제조방법
SE441355B (sv) Addukter av 1,8-dihydroxi-9-antron, forfarande for framstellning derav och kompositioner i synnerhet med effekt mot psoriasis och vartor
JPH0366690A (ja) フロ〔３，４―ｃ〕ピリジン誘導体の不斉合成製造法
US4552881A (en) Substituted and bridged pyridines useful as calcium channel blocker
NO172390B (no) Analogifremgangsmaate for stereospesifikk fremstilling av terapeutisk aktive furo(3,4-c)-pyridin-enantiomerer
EP1554277A1 (fr) Derives de pyrrolo[3,4-c]carbazole et de pyrido[2,3-b]pyrrolo[3,4-e]indole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US2924600A (en) Certificate of correction
US2958699A (en) Osmate esters of 1-carboalkoxy-methyl-2-(beta, gamma-dihydroxyisobutyl)-2, 4beta-dimethyl-4-keto-1, 2, 3, 4, 4a, 4b, 5, 6, 7, 8, 10, 10alpha-dodecahydrophenanthrene 7-ketals
EP0039091B1 (en) Spirobenzofuranone compounds
KR830000813B1 (ko) 2-(2-알콕시에틸)-2'-하이드록시-6, 7-벤조모르판의 제조방법
JPS6330490A (ja) アミノベンゾキサジノリフアマイシン誘導体
DE3927367A1 (de) Verfahren zur herstellung von dehydrocycloclausenamid und dessen derivate in der racemischen form und als optisch aktive (+) oder (-)-enantiomere
JPS62205083A (ja) ２−アルコキシカルボニル−８−メチル−６−オキソ−７−オキサデカヒドロイソキノリン

Legal Events

Date Code Title Description
NUG Patent has lapsed